Pathstone Holdings, LLC Coll Plant Biotechnologies LTD Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Pathstone Holdings, LLC holds 34,000 shares of CLGN stock, worth $107,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,000
Previous 17,000
100.0%
Holding current value
$107,100
Previous $43,000
6.98%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLGN
# of Institutions
20Shares Held
2.66MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC547KShares$1.72 Million0.08% of portfolio
-
Pinnacle Associates LTD507KShares$1.6 Million0.01% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.46 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$870,7542.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$866,5080.1% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $34.9M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...